DiaMedica Therapeutics Inc
NASDAQ:DMAC

Watchlist Manager
DiaMedica Therapeutics Inc Logo
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Watchlist
Price: 8.47 USD 1.44% Market Closed
Market Cap: 441.1m USD

Wall Street
Price Targets

DMAC Price Targets Summary
DiaMedica Therapeutics Inc

Wall Street analysts forecast DMAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.

Lowest
Price Target
11.11 USD
31% Upside
Average
Price Target
15.81 USD
87% Upside
Highest
Price Target
26.25 USD
210% Upside
DiaMedica Therapeutics Inc Competitors:
Price Targets
MRUS
Merus NV
3% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
36% Upside
CRSP
CRISPR Therapeutics AG
41% Upside
BMEA
Biomea Fusion Inc
453% Upside
ADOC
Adocia SA
144% Upside
688363
Bloomage Biotechnology Corp Ltd
9% Upside
9966
Alphamab Oncology
2% Downside
QURE
Uniqure NV
115% Upside

Revenue
Forecast

Revenue Estimate
DiaMedica Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
DiaMedica Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
DiaMedica Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DMAC's stock price target?
Price Target
15.81 USD

According to Wall Street analysts, the average 1-year price target for DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.

Back to Top